Art

J-GLOBAL ID：201402222964349627   Reference number：14A1344727

Phase II study of FOLFIRINOX for chemotherapy-naethve Japanese patients with metastatic pancreatic cancer

日本人化学療法感受性転移性膵臓癌患者のFOLFIRINOX第II相試験

Author (8)： OKUSAKA Takuji (Dep. of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, JPN) ,  IKEDA Masafumi ,  FUKUTOMI Akira ,  IOKA Tatsuya ,  FURUSE Junji ,  OHKAWA Shinichi ,  ISAYAMA Hiroyuki ,  BOKU Narikazu
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 105  Issue： 10  Page： 1321-1326  Publication year： Oct. 2014 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： Japanese ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1344727&from=J-GLOBAL&jstjournalNo=U0505A") }}

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Irinotecan ,  Leucovorin ,  Fluorouracil

Reference (17)：

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
• Japanese Ministry of Health, Labour and Welfare. Statistical investigation result. 2012: [cited 27 November 2013] Available from URL: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei12/index.html [In Japanese].
• Center for Cancer control and Information Services, Latest Cancer Statistics. [cited 21 November 2013] Available from URL: http://ganjoho.jp/public/statistics/pub/statistics01.html [In Japanese].
• Burris HA III, Moore MJ, Anderson J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403–13.
• Moore MJ, Goldstein D, Hamm J et al. Erlotnib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer instutite of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960–6.

Terms in the title (8)： 日本人 ,  化学療法 ,  感受性 ,  転移性 ,  膵臓癌 ,  患者 ,  FOLFIRINOX ,  第II相試験